PLoS Computational Biology (Mar 2021)

SARS-CoV-2 viral dynamics in non-human primates.

  • Antonio Gonçalves,
  • Pauline Maisonnasse,
  • Flora Donati,
  • Mélanie Albert,
  • Sylvie Behillil,
  • Vanessa Contreras,
  • Thibaut Naninck,
  • Romain Marlin,
  • Caroline Solas,
  • Andres Pizzorno,
  • Julien Lemaitre,
  • Nidhal Kahlaoui,
  • Olivier Terrier,
  • Raphael Ho Tsong Fang,
  • Vincent Enouf,
  • Nathalie Dereuddre-Bosquet,
  • Angela Brisebarre,
  • Franck Touret,
  • Catherine Chapon,
  • Bruno Hoen,
  • Bruno Lina,
  • Manuel Rosa Calatrava,
  • Xavier de Lamballerie,
  • France Mentré,
  • Roger Le Grand,
  • Sylvie van der Werf,
  • Jérémie Guedj

DOI
https://doi.org/10.1371/journal.pcbi.1008785
Journal volume & issue
Vol. 17, no. 3
p. e1008785

Abstract

Read online

Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques for which nasopharyngeal and tracheal viral load were frequently assessed. We identified that infected cells had a large burst size (>104 virus) and a within-host reproductive basic number of approximately 6 and 4 in nasopharyngeal and tracheal compartment, respectively. After peak viral load, infected cells were rapidly lost with a half-life of 9 hours, with no significant association between cytokine elevation and clearance, leading to a median time to viral clearance of 10 days, consistent with observations in mild human infections. Given these parameter estimates, we predict that a prophylactic treatment blocking 90% of viral production or viral infection could prevent viral growth. In conclusion, our results provide estimates of SARS-CoV-2 viral kinetic parameters in an experimental model of mild infection and they provide means to assess the efficacy of future antiviral treatments.